Kezar Life Sciences Ownership 2024 | Who Owns Kezar Life Sciences Now?
Institutional Ownership
5.90%
Insider Ownership
14.79%
Retail Ownership
79.30%
Institutional Holders
14.00
Kezar Life Sciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.85% | 0.16% | 7,167,591 | - | - | 4,300,555 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 6.90% | 0.13% | 5,026,000 | - | - | 3,015,600 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.77% | - | 2,741,105 | -353,119 | -11.41% | 1,644,663 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 2.82% | 0.17% | 2,051,676 | - | - | 1,231,006 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 2.65% | 0.02% | 1,927,000 | - | - | 1,156,200 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 2.55% | 0.00% | 1,855,194 | 64,356 | 3.59% | 1,112,000 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 2.42% | 0.12% | 1,761,778 | - | - | 1,057,067 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.58% | 0.00% | 1,148,181 | -154,073 | -11.83% | 688,909 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 1.49% | 0.12% | 1,086,498 | 849,875 | 359.17% | 651,899 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 1.44% | 0.58% | 1,050,452 | 1,050,452 | 100.00% | 630,271 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.40% | 0.00% | 1,019,176 | 614,470 | 151.83% | 611,505 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 1.36% | 0.32% | 986,785 | 295,956 | 42.84% | 592,071 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 1.19% | 0.09% | 868,992 | - | - | 521,395 | Jun 30, 2024 |
| BLACKROCK INC. | 1.14% | - | 830,371 | -3,786,617 | -82.01% | 498,222 | Jun 30, 2024 |
| QIMING U.S. VENTURES MANAGEMENT, LLC | 1.14% | 0.94% | 828,711 | - | - | 497,227 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.07% | 0.00% | 778,474 | -559,600 | -41.82% | 467,084 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.86% | 0.00% | 628,514 | -188,459 | -23.07% | 377,108 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.75% | - | 545,234 | -828,455 | -60.31% | 327,226 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.62% | - | 449,778 | -65,585 | -12.73% | 269,867,000 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.61% | 0.00% | 443,724 | 170,294 | 62.28% | 266,234 | Jun 30, 2024 |
Kezar Life Sciences's largest institutional shareholder is SUVRETTA CAPITAL MANAGEMENT, LLC, holding 9.85% of the company's total share outstanding, currently valued at $4.30M. The top 10 institutional shareholders own together 35.46% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| QIMING U.S. VENTURES MANAGEMENT, LLC | 1.14% | 0.94% | 828,711 | - | - | 497,227 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 1.44% | 0.58% | 1,050,452 | 1,050,452 | 100.00% | 630,271 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 1.36% | 0.32% | 986,785 | 295,956 | 42.84% | 592,071 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 2.82% | 0.17% | 2,051,676 | - | - | 1,231,006 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.85% | 0.16% | 7,167,591 | - | - | 4,300,555 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 6.90% | 0.13% | 5,026,000 | - | - | 3,015,600 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 1.49% | 0.12% | 1,086,498 | 849,875 | 359.17% | 651,899 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | 2.42% | 0.12% | 1,761,778 | - | - | 1,057,067 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 1.19% | 0.09% | 868,992 | - | - | 521,395 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 2.65% | 0.02% | 1,927,000 | - | - | 1,156,200 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.24% | 0.02% | 178,056 | 51,961 | 41.21% | 106,834 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.14% | 0.01% | 105,105 | 105,105 | 100.00% | 63,063 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.08% | 0.01% | 56,080 | -907,518 | -94.18% | 33,648 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.39% | 0.01% | 282,521 | 282,521 | 100.00% | 169,513 | Jun 30, 2024 |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 0.04% | 0.01% | 27,010 | -1,002 | -3.58% | 16,206 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.31% | 0.01% | 227,701 | 227,701 | 100.00% | 136,621 | Jun 30, 2024 |
| RETIREMENT CAPITAL STRATEGIES | 0.02% | 0.00% | 15,000 | - | - | 9,000 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 2.55% | 0.00% | 1,855,194 | 64,356 | 3.59% | 1,112,000 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.21% | 0.00% | 150,485 | - | - | 90,291 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.58% | 0.00% | 1,148,181 | -154,073 | -11.83% | 688,909 | Jun 30, 2024 |
The largest Kezar Life Sciences shareholder by % of total assets is QIMING U.S. VENTURES MANAGEMENT, LLC. The company owns 828.71K shares of Kezar Life Sciences (KZR), representing 0.94% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STONEPINE CAPITAL MANAGEMENT, LLC | 1.44% | 0.58% | 1,050,452 | 1,050,452 | 100.00% | 630,271 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 1.49% | 0.12% | 1,086,498 | 849,875 | 359.17% | 651,899 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.40% | 0.00% | 1,019,176 | 614,470 | 151.83% | 611,505 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 1.36% | 0.32% | 986,785 | 295,956 | 42.84% | 592,071 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.39% | 0.01% | 282,521 | 282,521 | 100.00% | 169,513 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.31% | 0.01% | 227,701 | 227,701 | 100.00% | 136,621 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.61% | 0.00% | 443,724 | 170,294 | 62.28% | 266,234 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.22% | 0.00% | 156,584 | 156,584 | 100.00% | 93,950 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.20% | 0.00% | 147,800 | 147,800 | 100.00% | 88,680 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.14% | 0.01% | 105,105 | 105,105 | 100.00% | 63,063 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.11% | 0.00% | 77,736 | 77,736 | 100.00% | 46,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.14% | - | 105,389 | 72,140 | 216.97% | 63,233 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 2.55% | 0.00% | 1,855,194 | 64,356 | 3.59% | 1,112,000 | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | 0.08% | 0.00% | 58,709 | 58,709 | 100.00% | 35,225 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.08% | 0.00% | 56,059 | 56,059 | 100.00% | 33,635 | Jun 30, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.24% | 0.02% | 178,056 | 51,961 | 41.21% | 106,834 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.06% | 0.00% | 44,400 | 44,400 | 100.00% | 26,640 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.06% | - | 40,837 | 40,837 | 100.00% | 24,502 | Jun 30, 2024 |
| FMR LLC | 0.09% | - | 62,288 | 40,199 | 181.99% | 37,373 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.11% | - | 83,600 | 35,926 | 75.36% | 51,000 | Jun 30, 2024 |
As of Jun 30 2024, Kezar Life Sciences's largest institutional buyer is STONEPINE CAPITAL MANAGEMENT, LLC. The company purchased 1.05M stocks of KZR, valued at $630.27K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 1.14% | - | 830,371 | -3,786,617 | -82.01% | 498,222 | Jun 30, 2024 |
| STATE STREET CORP | 0.26% | - | 185,941 | -937,833 | -83.45% | 111,565,000 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.08% | 0.01% | 56,080 | -907,518 | -94.18% | 33,648 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.75% | - | 545,234 | -828,455 | -60.31% | 327,226 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -688,943 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.07% | 0.00% | 778,474 | -559,600 | -41.82% | 467,084 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.77% | - | 2,741,105 | -353,119 | -11.41% | 1,644,663 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -314,762 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -282,595 | -100.00% | - | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | - | - | - | -233,206 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -214,264 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.86% | 0.00% | 628,514 | -188,459 | -23.07% | 377,108 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.34% | 0.00% | 246,841 | -172,584 | -41.15% | 148,104 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.09% | - | 63,358 | -163,132 | -72.03% | 38,015 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.58% | 0.00% | 1,148,181 | -154,073 | -11.83% | 688,909 | Jun 30, 2024 |
| MORGAN STANLEY | 0.01% | - | 7,125 | -94,026 | -92.96% | 4,276 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.03% | 0.00% | 18,550 | -82,251 | -81.60% | 11,130 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.04% | - | 27,551 | -81,884 | -74.82% | 16,529 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -79,058 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.62% | - | 449,778 | -65,585 | -12.73% | 269,867,000 | Jun 30, 2024 |
As of Jun 30 2024, Kezar Life Sciences's biggest institutional seller is BLACKROCK INC.. The company sold -3.79M shares of KZR, valued at $498.22K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STONEPINE CAPITAL MANAGEMENT, LLC | 1.44% | 0.58% | 1,050,452 | 1,050,452 | 100.00% | 630,271 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.39% | 0.01% | 282,521 | 282,521 | 100.00% | 169,513 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.31% | 0.01% | 227,701 | 227,701 | 100.00% | 136,621 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.20% | 0.00% | 147,800 | 147,800 | 100.00% | 88,680 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.14% | 0.01% | 105,105 | 105,105 | 100.00% | 63,063 | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | 0.08% | 0.00% | 58,709 | 58,709 | 100.00% | 35,225 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.08% | 0.00% | 56,059 | 56,059 | 100.00% | 33,635 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.06% | 0.00% | 44,400 | 44,400 | 100.00% | 26,640 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 35,794 | 35,794 | 100.00% | 21,476 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.03% | 0.00% | 22,625 | 22,625 | 100.00% | 13,575 | Jun 30, 2024 |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 0.02% | 0.00% | 12,608 | 12,608 | 100.00% | 7,565 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.02% | - | 11,898 | 11,898 | 100.00% | 7,139 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.02% | 0.00% | 11,669 | 11,669 | 100.00% | 7,001 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | 0.02% | 0.00% | 11,212 | 11,212 | 100.00% | 6,727 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 6,000 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.01% | - | 6,434 | 6,434 | 100.00% | 3,860 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.01% | - | 3,627 | 3,627 | 100.00% | 2,176 | Jun 30, 2024 |
Kezar Life Sciences's largest new institutional shareholder by number of shares is STONEPINE CAPITAL MANAGEMENT, LLC, purchased 1.05M shares, valued at $630.27K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -688,943 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -314,762 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -282,595 | -100.00% | - | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | - | - | - | -233,206 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -214,264 | -100.00% | - | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | - | - | - | -79,058 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -53,216 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -50,118 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -35,172 | -100.00% | - | Jun 30, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | - | - | - | -27,266 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -26,195 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -25,149 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -24,623 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -23,748 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -21,966 | -100.00% | - | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | - | - | - | -21,436 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -19,476 | -100.00% | - | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -18,980 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | - | - | - | -17,702 | -100.00% | - | Jun 30, 2024 |
| DIVERSIFIED TRUST CO | - | - | - | -16,132 | -100.00% | - | Jun 30, 2024 |
| PROSHARE ADVISORS LLC | - | - | - | -12,822 | -100.00% | - | Jun 30, 2024 |
| FIRST BANK & TRUST | - | - | - | -11,739 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -10,136 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -6,814 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -4,127 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -1,629 | -100.00% | - | Jun 30, 2024 |
| CAPITAL ADVISORS, LTD. LLC | - | - | - | -1,608 | -100.00% | - | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -50 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -13 | -100.00% | - | Jun 30, 2024 |
Kezar Life Sciences's largest sold out institutional shareholder by shares sold is TANG CAPITAL MANAGEMENT LLC, sold -0.69M shares, valued at -, as of undefined.
Kezar Life Sciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Manager Directed Portfolios | 3.66% | 600,079 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.19% | 184,619 | - | - | Jan 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.12% | 63,930 | - | - | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.08% | 638,139 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 37,867 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.05% | 449,150 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.04% | 97,000 | -50,000 | -34.01% | Mar 28, 2024 |
| FORUM FUNDS II | 0.04% | 39,640 | - | - | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.03% | 1,013,406 | - | - | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.03% | 71,027 | - | - | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.02% | 49,096 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.02% | 456 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 122,594 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.02% | 46,568 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 11,179 | - | - | Mar 31, 2024 |
| NEW COVENANT FUNDS | 0.01% | 45,653 | - | - | Dec 31, 2023 |
| ETFis Series Trust I | 0.01% | 14,036 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.01% | 96,456 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,642,285 | -764,730 | -22.45% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,311 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 226,490 | -118,950 | -34.43% | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 51,347 | - | - | Feb 29, 2024 |
| Nushares ETF Trust | 0.00% | 29,822 | - | - | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.00% | 40,264 | - | - | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 23,776 | - | - | Aug 31, 2023 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 266,288 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 237,620 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 506,958 | 48,285 | 10.53% | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 9,109 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 410,064 | -9,253 | -2.21% | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 254,558 | - | - | Jan 31, 2024 |
| Managed Portfolio Series | 0.00% | 36,199 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 4,127 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 43,585 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 25,260 | - | - | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 14,867 | -2,286 | -13.33% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 214,500 | - | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 29,376 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 3,601 | - | - | Mar 28, 2024 |
| TARGET PORTFOLIO TRUST | 0.00% | 16,400 | - | - | Jan 31, 2024 |
| Meeder Funds | 0.00% | 3,789 | - | - | Mar 31, 2024 |
| Victory Portfolios II | 0.00% | 35,136 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 3,139 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,657 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 258 | - | - | Apr 30, 2021 |
| JPMORGAN TRUST II | 0.00% | 464,438 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 14,080 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 27,452 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,049 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 40,954 | - | - | Feb 29, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 46,803 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 22,030 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,739 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 4,963 | 1,327 | 36.50% | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 57,644 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 207,567 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 23,793 | -17,683 | -42.63% | Mar 28, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 313,420 | 39,289 | 14.33% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 652 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 2,553,079 | -156,777 | -5.79% | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 16,700 | 800 | 5.03% | Mar 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 11,883 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 292,529 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 27,388 | -110 | -0.40% | Feb 29, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 2,600 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 10,798 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 323 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 8,576 | -76 | -0.88% | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,800 | - | - | Mar 28, 2024 |
| SPDR SERIES TRUST | 0.00% | 2,310,933 | - | - | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 3,761 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 20,187 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 554 | -46 | -7.67% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 20,529 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 10,457 | -3,203 | -23.45% | Feb 29, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 142,219 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 43 | - | - | Dec 31, 2023 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 8,053 | - | - | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 219 | - | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 3,133 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 2,244 | - | - | Feb 29, 2024 |
| GMO TRUST | 0.00% | 46,719 | - | - | Feb 29, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 102,858 | - | - | Mar 28, 2024 |
| Brighthouse Funds Trust II | 0.00% | 24,216 | - | - | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,356 | - | - | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 59,700 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 8,085 | -33 | -0.41% | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,957 | - | - | Feb 29, 2024 |
| Investment Managers Series Trust II | 0.00% | 219 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 18,676 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust I | 0.00% | 128,150 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 3,512 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 53,202 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 30,442 | - | - | Dec 31, 2023 |
| ALLSPRING FUNDS TRUST | 0.00% | 4,276 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 206 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 9,465 | - | - | Jan 31, 2024 |
| Goldman Sachs Trust II | 0.00% | 52,810 | - | - | Jan 31, 2024 |
| iShares U.S. ETF Trust | 0.00% | 1,030 | - | - | Jan 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 61,112 | - | - | Feb 29, 2024 |
Kezar Life Sciences's largest mutual fund holder by % of total assets is "Manager Directed Portfolios", owning 600.08K shares, compromising 3.66% of its total assets.
Kezar Life Sciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 14 | -83.72% |
| 31 Mar, 24 | 86 | 2.38% |
| 31 Dec, 23 | 84 | -5.62% |
| 30 Sep, 23 | 89 | -20.54% |
| 30 Jun, 23 | 112 | -22.76% |
| 31 Mar, 23 | 145 | 16.94% |
| 31 Dec, 22 | 124 | -8.82% |
| 30 Sep, 22 | 136 | -2.16% |
| 30 Jun, 22 | 139 | 7.75% |
| 31 Mar, 22 | 129 | 14.16% |
| 31 Dec, 21 | 113 | 44.87% |
| 30 Sep, 21 | 78 | 6.85% |
| 30 Jun, 21 | 73 | -14.12% |
| 31 Mar, 21 | 85 | 11.84% |
| 31 Dec, 20 | 76 | -2.56% |
| 30 Sep, 20 | 78 | -8.24% |
| 30 Jun, 20 | 85 | 44.07% |
| 31 Mar, 20 | 59 | 7.27% |
| 31 Dec, 19 | 55 | 1.85% |
| 30 Sep, 19 | 54 | 1.89% |
| 30 Jun, 19 | 53 | 6.00% |
| 31 Mar, 19 | 50 | 25.00% |
| 31 Dec, 18 | 40 | 8.11% |
| 30 Sep, 18 | 37 | 37.04% |
| 30 Jun, 18 | 27 | - |
As of 30 Jun 24, 14 institutions are holding Kezar Life Sciences's shares, representing a decrease of -83.72% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 4,297,572 | -90.40% |
| 31 Mar, 24 | 44,760,196 | -9.36% |
| 31 Dec, 23 | 49,383,993 | -10.99% |
| 30 Sep, 23 | 55,483,503 | -2.43% |
| 30 Jun, 23 | 56,865,250 | -5.32% |
| 31 Mar, 23 | 60,060,664 | 4.86% |
| 31 Dec, 22 | 57,277,372 | -0.30% |
| 30 Sep, 22 | 57,449,024 | 4.76% |
| 30 Jun, 22 | 54,840,354 | 24.39% |
| 31 Mar, 22 | 44,087,341 | 9.44% |
| 31 Dec, 21 | 40,282,904 | 43.49% |
| 30 Sep, 21 | 28,072,732 | 1.55% |
| 30 Jun, 21 | 27,644,039 | 3.07% |
| 31 Mar, 21 | 26,821,886 | 13.95% |
| 31 Dec, 20 | 23,537,588 | 1.55% |
| 30 Sep, 20 | 23,177,542 | 0.34% |
| 30 Jun, 20 | 23,099,925 | 24.92% |
| 31 Mar, 20 | 18,491,708 | 101.58% |
| 31 Dec, 19 | 9,173,566 | -2.67% |
| 30 Sep, 19 | 9,425,080 | -5.86% |
| 30 Jun, 19 | 10,011,675 | 0.97% |
| 31 Mar, 19 | 9,915,074 | 6.18% |
| 31 Dec, 18 | 9,337,661 | 3.13% |
| 30 Sep, 18 | 9,054,019 | 10.92% |
| 30 Jun, 18 | 8,162,306 | - |
Kezar Life Sciences (KZR) has 4.30M shares outstanding as of 30 Jun 24, down -90.40% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 5.90% | 0.16% |
| 31 Mar, 24 | 61.69% | 1.34% |
| 31 Dec, 23 | 67.95% | 1.16% |
| 30 Sep, 23 | 76.57% | 1.24% |
| 30 Jun, 23 | 78.62% | 1.14% |
| 31 Mar, 23 | 83.04% | 1.32% |
| 31 Dec, 22 | 79.30% | 1.25% |
| 30 Sep, 22 | 79.62% | 1.09% |
| 30 Jun, 22 | 85.32% | 1.61% |
| 31 Mar, 22 | 72.71% | 1.25% |
| 31 Dec, 21 | 76.35% | 2.62% |
| 30 Sep, 21 | 53.94% | 1.90% |
| 30 Jun, 21 | 53.26% | 1.93% |
| 31 Mar, 21 | 52.53% | 2.38% |
| 31 Dec, 20 | 47.00% | 2.19% |
| 30 Sep, 20 | 46.36% | 1.60% |
| 30 Jun, 20 | 53.80% | 1.70% |
| 31 Mar, 20 | 56.26% | 2.43% |
| 31 Dec, 19 | 48.07% | 1.97% |
| 30 Sep, 19 | 49.36% | 1.79% |
| 30 Jun, 19 | 52.49% | 1.94% |
| 31 Mar, 19 | 52.07% | 2.16% |
| 31 Dec, 18 | 49.13% | 2.16% |
| 30 Sep, 18 | 47.64% | 2.58% |
| 30 Jun, 18 | 42.95% | - |
As of 30 Jun 24, Kezar Life Sciences is held by 5.90% institutional shareholders, representing a 0.16% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | -78.95% |
| 31 Mar, 24 | 38 | -5.00% |
| 31 Dec, 23 | 40 | 2.56% |
| 30 Sep, 23 | 39 | -27.78% |
| 30 Jun, 23 | 54 | -34.94% |
| 31 Mar, 23 | 83 | 29.69% |
| 31 Dec, 22 | 64 | -24.71% |
| 30 Sep, 22 | 85 | 6.25% |
| 30 Jun, 22 | 80 | 14.29% |
| 31 Mar, 22 | 70 | -2.78% |
| 31 Dec, 21 | 72 | 84.62% |
| 30 Sep, 21 | 39 | 14.71% |
| 30 Jun, 21 | 34 | -5.56% |
| 31 Mar, 21 | 36 | -7.69% |
| 31 Dec, 20 | 39 | 5.41% |
| 30 Sep, 20 | 37 | -35.09% |
| 30 Jun, 20 | 57 | 39.02% |
| 31 Mar, 20 | 41 | 32.26% |
| 31 Dec, 19 | 31 | -6.06% |
| 30 Sep, 19 | 33 | -13.16% |
| 30 Jun, 19 | 38 | -7.32% |
| 31 Mar, 19 | 41 | 64.00% |
| 31 Dec, 18 | 25 | - |
| 30 Sep, 18 | 25 | -7.41% |
| 30 Jun, 18 | 27 | - |
8 institutional shareholders have increased their position in KZR stock as of 30 Jun 24 compared to 38 in the previous quarter (a -78.95% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 4 | -85.71% |
| 31 Mar, 24 | 28 | 7.69% |
| 31 Dec, 23 | 26 | -18.75% |
| 30 Sep, 23 | 32 | -3.03% |
| 30 Jun, 23 | 33 | -17.50% |
| 31 Mar, 23 | 40 | -2.44% |
| 31 Dec, 22 | 41 | 36.67% |
| 30 Sep, 22 | 30 | -11.76% |
| 30 Jun, 22 | 34 | -17.07% |
| 31 Mar, 22 | 41 | 78.26% |
| 31 Dec, 21 | 23 | - |
| 30 Sep, 21 | 23 | -11.54% |
| 30 Jun, 21 | 26 | -18.75% |
| 31 Mar, 21 | 32 | 33.33% |
| 31 Dec, 20 | 24 | -17.24% |
| 30 Sep, 20 | 29 | 52.63% |
| 30 Jun, 20 | 19 | 18.75% |
| 31 Mar, 20 | 16 | 6.67% |
| 31 Dec, 19 | 15 | 66.67% |
| 30 Sep, 19 | 9 | - |
| 30 Jun, 19 | 9 | 50.00% |
| 31 Mar, 19 | 6 | -33.33% |
| 31 Dec, 18 | 9 | 12.50% |
| 30 Sep, 18 | 8 | - |
| 30 Jun, 18 | - | - |
4 institutional shareholders have reduced their position in KZR stock as of 30 Jun 24 compared to 28 in the previous quarter (a -85.71% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 14 | -83.72% | 4,297,572 | -90.40% | 5.90% | 0.16% | 8 | -78.95% | 4 | -85.71% |
| 31 Mar, 24 | 86 | 2.38% | 44,760,196 | -9.36% | 61.69% | 1.34% | 38 | -5.00% | 28 | 7.69% |
| 31 Dec, 23 | 84 | -5.62% | 49,383,993 | -10.99% | 67.95% | 1.16% | 40 | 2.56% | 26 | -18.75% |
| 30 Sep, 23 | 89 | -20.54% | 55,483,503 | -2.43% | 76.57% | 1.24% | 39 | -27.78% | 32 | -3.03% |
| 30 Jun, 23 | 112 | -22.76% | 56,865,250 | -5.32% | 78.62% | 1.14% | 54 | -34.94% | 33 | -17.50% |
| 31 Mar, 23 | 145 | 16.94% | 60,060,664 | 4.86% | 83.04% | 1.32% | 83 | 29.69% | 40 | -2.44% |
| 31 Dec, 22 | 124 | -8.82% | 57,277,372 | -0.30% | 79.30% | 1.25% | 64 | -24.71% | 41 | 36.67% |
| 30 Sep, 22 | 136 | -2.16% | 57,449,024 | 4.76% | 79.62% | 1.09% | 85 | 6.25% | 30 | -11.76% |
| 30 Jun, 22 | 139 | 7.75% | 54,840,354 | 24.39% | 85.32% | 1.61% | 80 | 14.29% | 34 | -17.07% |
| 31 Mar, 22 | 129 | 14.16% | 44,087,341 | 9.44% | 72.71% | 1.25% | 70 | -2.78% | 41 | 78.26% |
| 31 Dec, 21 | 113 | 44.87% | 40,282,904 | 43.49% | 76.35% | 2.62% | 72 | 84.62% | 23 | - |
| 30 Sep, 21 | 78 | 6.85% | 28,072,732 | 1.55% | 53.94% | 1.90% | 39 | 14.71% | 23 | -11.54% |
| 30 Jun, 21 | 73 | -14.12% | 27,644,039 | 3.07% | 53.26% | 1.93% | 34 | -5.56% | 26 | -18.75% |
| 31 Mar, 21 | 85 | 11.84% | 26,821,886 | 13.95% | 52.53% | 2.38% | 36 | -7.69% | 32 | 33.33% |
| 31 Dec, 20 | 76 | -2.56% | 23,537,588 | 1.55% | 47.00% | 2.19% | 39 | 5.41% | 24 | -17.24% |
| 30 Sep, 20 | 78 | -8.24% | 23,177,542 | 0.34% | 46.36% | 1.60% | 37 | -35.09% | 29 | 52.63% |
| 30 Jun, 20 | 85 | 44.07% | 23,099,925 | 24.92% | 53.80% | 1.70% | 57 | 39.02% | 19 | 18.75% |
| 31 Mar, 20 | 59 | 7.27% | 18,491,708 | 101.58% | 56.26% | 2.43% | 41 | 32.26% | 16 | 6.67% |
| 31 Dec, 19 | 55 | 1.85% | 9,173,566 | -2.67% | 48.07% | 1.97% | 31 | -6.06% | 15 | 66.67% |
| 30 Sep, 19 | 54 | 1.89% | 9,425,080 | -5.86% | 49.36% | 1.79% | 33 | -13.16% | 9 | - |
| 30 Jun, 19 | 53 | 6.00% | 10,011,675 | 0.97% | 52.49% | 1.94% | 38 | -7.32% | 9 | 50.00% |
| 31 Mar, 19 | 50 | 25.00% | 9,915,074 | 6.18% | 52.07% | 2.16% | 41 | 64.00% | 6 | -33.33% |
| 31 Dec, 18 | 40 | 8.11% | 9,337,661 | 3.13% | 49.13% | 2.16% | 25 | - | 9 | 12.50% |
| 30 Sep, 18 | 37 | 37.04% | 9,054,019 | 10.92% | 47.64% | 2.58% | 25 | -7.41% | 8 | - |
| 30 Jun, 18 | 27 | - | 8,162,306 | - | 42.95% | - | 27 | - | - | - |
Kezar Life Sciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Kezar Life Sciences's stock was made by Schiller Mark C. on Jul 26 2024, selling 6,688 shares at $0.58 per share (valued at $3.88K).
Kezar Life Sciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 6 | - | - |
| Q1 2024 | 2 | 3 | 66.67% |
| Q4 2023 | 1 | - | - |
| Q3 2023 | 34 | 43 | 79.07% |
| Q2 2023 | 6 | - | - |
| Q1 2023 | 5 | 16 | 31.25% |
| Q4 2022 | 1 | 4 | 25.00% |
| Q3 2022 | 1 | - | - |
| Q2 2022 | 10 | 1 | 1000.00% |
| Q1 2022 | 8 | 2 | 400.00% |
| Q4 2021 | 2 | 1 | 200.00% |
| Q3 2021 | 3 | 3 | 100.00% |
| Q2 2021 | 8 | - | - |
| Q1 2021 | 5 | - | - |
| Q4 2020 | 1 | 1 | 100.00% |
| Q2 2020 | 9 | - | - |
| Q1 2020 | 10 | 1 | 1000.00% |
| Q4 2019 | 4 | 1 | 400.00% |
| Q3 2019 | 14 | - | - |
| Q2 2019 | 6 | - | - |
6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Kezar Life Sciences's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 16 | - |
| Q4 2022 | - | 3 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | 3 | 1 | 300.00% |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q2 2020 | 2 | - | - |
| Q1 2020 | 6 | - | - |
| Q4 2019 | 2 | - | - |
| Q3 2019 | 12 | - | - |
| Q2 2019 | 1 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Kezar Life Sciences's stocks.
Kezar Life Sciences Peer Ownership
| Ticker | Company |
|---|---|
| NGM | NGM Biopharmaceuticals, Inc. |
| NRIX | Nurix Therapeutics, Inc. |
| KYMR | Kymera Therapeutics, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| IKNA | Ikena Oncology, Inc. |
| LRMR | Larimar Therapeutics, Inc. |
| FHTX | Foghorn Therapeutics Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| IPSC | Century Therapeutics, Inc. |
| SRZN | Surrozen, Inc. |
| LYEL | Lyell Immunopharma, Inc. |
| BOLT | Bolt Biotherapeutics, Inc. |
| KROS | Keros Therapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| NKTX | Nkarta, Inc. |
| STTK | Shattuck Labs, Inc. |
KZR Ownership FAQ
Who Owns Kezar Life Sciences?
Kezar Life Sciences is owned by institutional shareholders (5.90%), insiders (14.79%), and public (79.30%). The largest institutional shareholder of Kezar Life Sciences is SUVRETTA CAPITAL MANAGEMENT, LLC (9.85% of total shares) and the top mutual fund owner is Manager Directed Portfolios (3.66% of total shares).
Who are the major institutional shareholders of Kezar Life Sciences?
Kezar Life Sciences's major institutional shareholders are SUVRETTA CAPITAL MANAGEMENT, LLC, AVIDITY PARTNERS MANAGEMENT LP, VANGUARD GROUP INC, SPHERA FUNDS MANAGEMENT LTD., and ORBIMED ADVISORS LLC. The top five shareholders own together 25.98% of the company's share outstanding.
How many Kezar Life Sciences shareholders are there?
As of Jun 2024, there are 14 institutional shareholders of Kezar Life Sciences.
What percentage of Kezar Life Sciences is owned by SUVRETTA CAPITAL MANAGEMENT, LLC?
SUVRETTA CAPITAL MANAGEMENT, LLC owns 7.17M shares of Kezar Life Sciences, representing 9.85% of the company's total shares outstanding, valued at $4.3M (as of Jun 2024).
What percentage of Kezar Life Sciences is owned by AVIDITY PARTNERS MANAGEMENT LP?
As of Jun 2024, AVIDITY PARTNERS MANAGEMENT LP holds 5.03M shares of Kezar Life Sciences (KZR), compromising 6.90% of the company, valued at $3.02M.
What percentage of Kezar Life Sciences is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Kezar Life Sciences. The company owns 2.74M of the company's shares outstanding (worth $1.64M).